Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,008 public trials 530 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.

NCT00812968

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Celgene Clinical Site Shimono, Tochigi, Japan
  • Celgene Clinical Site Shibuya-ku, Tokyo, Japan
  • Celgene Clinical Site Hiroshima, Japan
  • Celgene Clinical Site Kyoto, Japan
View Trial Details
Completed

Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality

NCT00065156

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Arizona Cancer Center Scottsdale, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • Desert Hematology & Oncology Medical Group Rancho Mirage, California, United States
View all 32 locations
View Trial Details
Completed

Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies

NCT02164071

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Bronchial Diseases, +31 more
Locations
  • Hospital Txagorritxu Vitoria-Gasteiz, Alava, Spain
  • Hospital Sant Joan de Deu Espluges de Llobregat, Barcelona, Spain
  • Hospital Duran I Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Parc Tauli Sabadell, Barcelona, Spain
View all 22 locations
View Trial Details
Completed

Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea

NCT02137629

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Hallym University Sacred Heart Hospital Anyang, South Korea
  • Soon Chun Hyang University Hospital Bucheon Bucheon-si, South Korea
  • Kosin University Gospel Hospital Busan, South Korea
  • Dong-a University Medical Center Busan, South Korea
View all 48 locations
View Trial Details
Completed

MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry

NCT01347944

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Dipartimento Onco - Ematologico Azienda Ospedaliera SS Antonio, Biagio e Cesare Arrigo Alessandria, Italy
  • Unità Operativa Clinica di Ematologia Azianda Ospedaliero Universitaria Ospedali Riuniti di Ancona Ancona, Italy
  • Dipartimento di Oncologia Medica Ospedale Cardinale G. Massaia Asti, Italy
  • Ematologia Azienda Ospedaliera Universitaria Policlinico di Bari Bari, Italy
View all 45 locations
View Trial Details
Completed

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

NCT01929408

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • University of Maryland Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

NCT00008177

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +34 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions